# Allo-Allo Tandem Bone Marrow Transplant (BMT)

> **NCT00984412** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 15 (estimated)

## Conditions studied

- Refractory Acute Leukemia

## Interventions

- **PROCEDURE:** Allogeneic hematopoietic stem-cell-transplantation

## Key facts

- **NCT ID:** NCT00984412
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2020-04
- **Final completion:** 2020-11
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2016-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984412, "Allo-Allo Tandem Bone Marrow Transplant (BMT)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00984412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*